| Detected | Trial | Change |
|---|---|---|
| 2026-05-16 | NCT04423211 Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… |
Trial sites expanded: 303 -> 342 locations |
| 2026-05-14 | NCT07455903 Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients… |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04423211 | Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted… | Biochemically Recurrent Prostate Carcinoma | Recruiting |
| NCT04455750 | A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With… | Castration-Resistant Prostate Carcinoma | Active, Not Recruiting |
| NCT04513717 | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT05050084 | Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT02799706 | Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH… | Prostate Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT04734730 | Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of… | Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT07335796 | A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer | Prostate Cancer | Recruiting |
| NCT06378866 | Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway… | Recurrent Castration-Sensitive Prostate Carcinoma | Recruiting |
| NCT05501704 | ETHAN - ET for Male BC | Male Breast Cancer | Recruiting |
| NCT05873192 | Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate… | Prostate Cancer | Recruiting |
| NCT07455903 | Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients… | Prostate Cancer | Recruiting |
| NCT01746849 | Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total… | Leukemia | Active, Not Recruiting |
| NCT01786265 | Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating… | Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT03361735 | Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in… | Prostate Adenocarcinoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04989946 | Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint… | Prostate Cancer | Recruiting |
| Phase 1 | |||
| NCT05617885 | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | Metastatic Prostate Cancer | Active, Not Recruiting |
| Not specified | |||
| NCT02346253 | High-Dose Brachytherapy in Treating Patients With Prostate Cancer | Prostate Adenocarcinoma | Active, Not Recruiting |